Latest News

We have written about the potential weight loss drug Tesofensine in the past and we have now become aware of an issue with the Phase II clinical trials in Denmark that we should expose to our readers...

The Danish bio pharma company, Neurosearch, will not seek to develop tesofensine, the obesity drug, by itself and instead seeks a partner in order to continue development with a view to eventually getting it on the market following the guidance of the FDA and EMA in the form of the outline of a clin...

Neurosearch, a Danish biopharmaceutical company that researches drugs, which act on the central nervous system, had been preparing to commence phase III trials of their obesity drug Tesofensine...

Neurosearch, the experimental drug company, has announced that they are continuing with plans to launch Stage III trials into their new slimming pill, Tesofensine...

The Scandanavian drug company Neurosearch has announced that they will present their annual report on the 10th of March...